Efficacy of a Deep Learning Convolutional Neural Network System for Melanoma Diagnosis in a Hospital Population
Overview
Public Health
Affiliations
(1) Background: The purpose of this study was to evaluate the efficacy in terms of sensitivity, specificity, and accuracy of the quantusSKIN system, a new clinical tool based on deep learning, to distinguish between benign skin lesions and melanoma in a hospital population. (2) Methods: A retrospective study was performed using 232 dermoscopic images from the clinical database of the Ramón y Cajal University Hospital (Madrid, Spain). The skin lesions images, previously diagnosed as nevus (n = 177) or melanoma (n = 55), were analyzed by the quantusSKIN system, which offers a probabilistic percentage (diagnostic threshold) for melanoma diagnosis. The optimum diagnostic threshold, sensitivity, specificity, and accuracy of the quantusSKIN system to diagnose melanoma were quantified. (3) Results: The mean diagnostic threshold was statistically lower (p < 0.001) in the nevus group (27.12 ± 35.44%) compared with the melanoma group (72.50 ± 34.03%). The area under the ROC curve was 0.813. For a diagnostic threshold of 67.33%, a sensitivity of 0.691, a specificity of 0.802, and an accuracy of 0.776 were obtained. (4) Conclusions: The quantusSKIN system is proposed as a useful screening tool for melanoma detection to be incorporated in primary health care systems.
Artificial Intelligence in the Non-Invasive Detection of Melanoma.
Mendi B, Kose K, Fleshner L, Adam R, Safai B, Farabi B Life (Basel). 2025; 14(12).
PMID: 39768310 PMC: 11678477. DOI: 10.3390/life14121602.
Wang W, Chen X, Xu L, Huang K, Zhao S, Wang Y J Med Internet Res. 2024; 26():e52914.
PMID: 39729353 PMC: 11724214. DOI: 10.2196/52914.
Karampinis E, Toli O, Georgopoulou K, Kampra E, Spyridonidou C, Roussaki Schulze A Diagnostics (Basel). 2024; 14(11).
PMID: 38893694 PMC: 11171543. DOI: 10.3390/diagnostics14111165.
Miller I, Rosic N, Stapelberg M, Hudson J, Coxon P, Furness J Cancers (Basel). 2024; 16(7).
PMID: 38611119 PMC: 11011068. DOI: 10.3390/cancers16071443.
Patel R, Foltz E, Witkowski A, Ludzik J Cancers (Basel). 2023; 15(19).
PMID: 37835388 PMC: 10571810. DOI: 10.3390/cancers15194694.